Kanchan Vats
B.Pharm, M.Pharm
Tata 1mg | Team Lead, Medical Affairs
6 Years Experience
About
Kanchan Vats is working as a team lead in the medical affairs team. Kanchan did her masters in Pharmacology and Toxicology MS(Pharm) from one of the reputed institutes of India, National Institute Of Pharmaceutical Education & Research (NIPER), Ahmedabad. She has qualified two national level exams, i.e., NIPER JEE and Graduate Pharmacy Aptitude Test (GPAT). She was associated with Training and Development team for more than 3 years with Intas Pharmaceuticals Pvt. Limited, Ahmedabad. She was awarded as the
Qualifications and Experience
Education
M.Pharm | National Institute Of Pharmaceutical Education and Research (NIPER), Ahmedabad | 2016 - 2018
B.Pharm | Abdul Kalam Technical University (AKTU), Uttar Pradesh | 2012 - 2016
Experience
Intas Pharmaceuticals Limited, Ahmedabad | Senior Executive | 2018 - 2021
Tata 1mg | Team Lead, Medical Affairs | 2021 - 2024
Research Publications
Intra-arterial Stem Cell Therapy Diminishes Inflammasome Activation After Ischemic Stroke: a Possible Role of Acid Sensing Ion Channel 1a.
Inflammasomes in stroke: a triggering role for acid-sensing ion channels.
Mitochondrial Dysfunction in Stroke: Implications of Stem Cell Therapy.
Intra-arterial stem cell therapy modulates neuronal calcineurin and confers neuroprotection after ischemic stroke.
Trigonelline therapy confers neuroprotection by reduced glutathione mediated myeloperoxidase expression in animal model of ischemic stroke.
Noncoding RNAs in ischemic stroke: time to translate.
Inflammasome Mediated Reduction of Myeloperoxidase in Ischemic Stroke by Intra-arterial Mesenchymal Stem Cell Therapy.
Intra-arterial mesenchymal stem cell therapy modulates inflammasome to confer neuroprotection in animal model of ischemic stroke.
Intra-Arterial Mesenchymal Stem Cell Therapy Modulates Expression of NLRP1 Inflammasome in Animal Model of Ischemic Stroke